Fuller & Thaler Asset Management’s Idexx Laboratories IDXX Stock Holding History

Fuller & Thaler Asset Management’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$244K	Hold	434	–	–	﹤0.01%	493
2025 Q4	$294K	Hold	434	–	–	﹤0.01%	486
2025 Q3	$277K	Hold	434	–	–	﹤0.01%	484
2025 Q2	$233K	Hold	434	–	–	﹤0.01%	492
2025 Q1	$182K	Hold	434	–	–	﹤0.01%	501
2024 Q4	$179K	Sell	434 -16	-4%	-$7.02K	﹤0.01%	508
2024 Q3	$227K	Hold	450	–	–	﹤0.01%	499
2024 Q2	$219K	Hold	450	–	–	﹤0.01%	490
2024 Q1	$243K	Hold	450	–	–	﹤0.01%	446
2023 Q4	$250K	Buy	450 +77	+21%	+$36.1K	﹤0.01%	428
2023 Q3	$163K	Hold	373	–	–	﹤0.01%	424
2023 Q2	$187K	Buy	373 +80	+27%	+$38.3K	﹤0.01%	427
2023 Q1	$147K	Hold	293	–	–	﹤0.01%	428
2022 Q4	$120K	Sell	293 -175	-37%	-$67.9K	﹤0.01%	422
2022 Q3	$152K	Sell	468 -150	-24%	-$55.1K	﹤0.01%	423
2022 Q2	$217K	Sell	618 -300	-33%	-$122K	﹤0.01%	435
2022 Q1	$502K	Sell	918 -300	-25%	-$158K	﹤0.01%	424
2021 Q4	$802K	Sell	1,218 -200	-14%	-$126K	﹤0.01%	409
2021 Q3	$882K	Sell	1,418 -100	-7%	-$67.2K	0.01%	397
2021 Q2	$959K	Sell	1,518 -300	-17%	-$166K	0.01%	393
2021 Q1	$890K	Sell	1,818 -400	-18%	-$200K	0.01%	380
2020 Q4	$1.11M	Buy	2,218 +4	+0.2%	+$1.79K	0.01%	353
2020 Q3	$870K	Hold	2,214	–	–	0.01%	350
2020 Q2	$731K	Hold	2,214	–	–	0.01%	335
2020 Q1	$536K	Sell	2,214 -7,533	-77%	-$1.97M	0.01%	335
2019 Q4	$2.54M	Sell	9,747 -5	-0.1%	-$1.32K	0.03%	272
2019 Q3	$2.65M	Hold	9,752	–	–	0.03%	255
2019 Q2	$2.69M	Sell	9,752 -1,505	-13%	-$371K	0.03%	261
2019 Q1	$2.52M	Sell	11,257 -2,583	-19%	-$533K	0.03%	250
2018 Q4	$2.58M	Sell	13,840 -3,835	-22%	-$786K	0.04%	245
2018 Q3	$4.41M	Sell	17,675 -4,405	-20%	-$1.07M	0.05%	227
2018 Q2	$4.81M	Sell	22,080 -5,612	-20%	-$1.16M	0.05%	212
2018 Q1	$5.3M	Sell	27,692 -393	-1%	-$72.5K	0.06%	193
2017 Q4	$4.39M	Buy	28,085 +1,785	+7%	+$281K	0.05%	189
2017 Q3	$4.09M	Sell	26,300 -1,400	-5%	-$221K	0.05%	186
2017 Q2	$4.47M	Sell	27,700 -2,000	-7%	-$325K	0.06%	160
2017 Q1	$4.59M	Buy	29,700 +3,500	+13%	+$482K	0.06%	157
2016 Q4	$3.07M	Buy	26,200 +5,200	+25%	+$593K	0.05%	177
2016 Q3	$2.37M	Buy	21,000 +19,700	+1,515%	+$2.08M	0.04%	183
2016 Q2	$121K	Buy	+1,300	New	+$112K	﹤0.01%	403
2015 Q2	–	Sell	-1,400	Closed	-$108K	–	703
2015 Q1	$108K	Sell	1,400 -400	-22%	-$31.1K	﹤0.01%	488
2014 Q4	$133K	Hold	1,800	–	–	﹤0.01%	447
2014 Q3	$106K	Sell	1,800 -800	-31%	-$50.6K	﹤0.01%	527
2014 Q2	$174K	Hold	2,600	–	–	0.01%	462
2014 Q1	$158K	Buy	2,600 +1,200	+86%	+$71.5K	0.01%	493
2013 Q4	$74K	Hold	1,400	–	–	﹤0.01%	583
2013 Q3	$70K	Buy	1,400 +200	+17%	+$9.61K	﹤0.01%	591
2013 Q2	$54K	Buy	+1,200	New	+$52.4K	﹤0.01%	606

Other funds holding IDXX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fuller & Thaler Asset Management's IDXX Position: Q1 2026 in Review

Fuller & Thaler Asset Management held its Idexx Laboratories (IDXX) position steady in Q1 2026 at 434 shares worth $244K. The position accounts for ﹤0.01% of the portfolio, ranked #493.

Fuller & Thaler Asset Management first reported a position in IDXX in Q2 2013 and has held it in 48 quarters since. The position peaked at $5.3M in Q1 2018. 1,311 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

Fuller & Thaler Asset Management held 434 shares of Idexx Laboratories worth $244K as of Q1 2026.
Fuller & Thaler Asset Management left its Idexx Laboratories share count unchanged in Q1 2026.
Idexx Laboratories made up ﹤0.01% of Fuller & Thaler Asset Management's portfolio in Q1 2026, its #493 holding.
Fuller & Thaler Asset Management first reported a position in Idexx Laboratories in Q2 2013 and has held it in 48 quarters since.
Fuller & Thaler Asset Management's Idexx Laboratories position peaked at $5.3M in Q1 2018.
1,311 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Fuller & Thaler Asset Management's 13F filing for Q1 2026, filed 14 May 2026.